Artelo Biosciences Stock Price

-0.017 (-2.95%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Artelo Biosciences Inc ARTL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.017 -2.95% 0.56 19:51:30
Open Price Low Price High Price Close Price Previous Close
0.59 0.551 0.59 0.5555 0.577
Bid Price Ask Price Spread News
0.56 0.569 0.009 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3,081 1,903,605 $ 0.5614536 $ 1,068,786 2,241,212 0.451 - 4.4234
Last Trade Time Type Quantity Stock Price Currency
19:53:23 20 $ 0.56 USD

Artelo Biosciences Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 8.46M 15.11M 14.76M $ - $ - -1.27 -0.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 6.20%

more financials information »

Artelo Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ARTL Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.570.750.5070.58919534,743,003-0.01-1.75%
1 Month0.600.750.4510.56342952,008,627-0.04-6.67%
3 Months0.941.500.4510.73064711,754,488-0.38-40.43%
6 Months1.301.800.4510.85514521,070,853-0.74-56.92%
1 Year2.974.42340.4511.03633,375-2.41-81.14%
3 Years4.955.000.4511.07454,559-4.39-88.69%
5 Years4.955.000.4511.07454,559-4.39-88.69%

Artelo Biosciences Description

Artelo Biosciences Inc is a United States based development-stage biopharmaceutical company. It is focused on discovering, licensing, developing and commercializing treatments that control the endocannabinoid system. The company seeks to pursue technologies and programs that offer proprietary approaches to cannabinoid-based therapies, including those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds that promote the effectiveness of the endocannabinoid system. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.

Your Recent History
Artelo Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.